Citius Pharmaceuticals, Inc. (CTXR) Reports Q1 Loss of $0.06
Tweet
Share
E-mailGet Alerts CTXR Hot Sheet
Join SI Premium – FREE
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) reported Q1 EPS of ($0.06).
For earnings history and earnings-related data on Citius Pharmaceuticals, Inc. (CTXR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
- Zscaler (ZS) Tops Q4 EPS by 10c
- Planet Labs (PL) Tops Q2 EPS by 4c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Citi, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
